ADAP
Mitsubishi UFJ Asset Management’s Adaptimmune Therapeutics ADAP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-74,256
| Closed | -$153K | – | 1140 |
|
|
2022
Q1 | $153K | Buy |
74,256
+5,116
| +7% | +$10.5K | ﹤0.01% | 1094 |
|
|
2021
Q4 | $281K | Buy |
69,140
+8,292
| +14% | +$33.7K | ﹤0.01% | 1022 |
|
|
2021
Q3 | $315K | Hold |
60,848
| – | – | ﹤0.01% | 1006 |
|
|
2021
Q2 | $259K | Sell |
60,848
-16,072
| -21% | -$68.4K | ﹤0.01% | 1056 |
|
|
2021
Q1 | $408K | Buy |
76,920
+26,013
| +51% | +$138K | ﹤0.01% | 912 |
|
|
2020
Q4 | $274K | Buy |
+50,907
| New | +$274K | ﹤0.01% | 919 |
|
|
2019
Q2 | – | Sell |
-28,621
| Closed | -$123K | – | 993 |
|
|
2019
Q1 | $123K | Buy |
28,621
+2,280
| +9% | +$9.8K | ﹤0.01% | 855 |
|
|
2018
Q4 | $141K | Buy |
26,341
+15,361
| +140% | +$82.2K | ﹤0.01% | 793 |
|
|
2018
Q3 | $149K | Buy |
+10,980
| New | +$149K | ﹤0.01% | 805 |
|